FDA approved device for fat tissue reduction in abdomen
- Trial ID:
- IRB-22-7972
- E. Victor Ross, M.D.
Inclusion Criteria
Patients must:
- - Be 18-65 years of age
- Agree to refrain from any new abdominal training exercises during the course of the study
- Have BMI of 30 or less
- Able to undergo MRI Imaging
- Meet all other eligibility criteria
Exclusion Criteria
Patients must not:
- - Be pregnant, intending to become pregnant, or nursing
- Have any previous liposuction/lipo-sculpture or any type of surgical procedure in the treatment area in the past 12 months
- Have a history of immunosuppression/immune deficiency disorders (including AIDS and HIV infection) or use of immunosuppressive medications in the last 6 months prior to and during the course of the study
- Have a history of hyperlipidemia, diabetes mellitus, hepatitis, blood coagulopathy or excessive bleeding, or cancer
- Have a permanent implant in the treatment area
- Use medications, herbs, food supplements, and vitamins known to induce photosensitivity to light exposure at the wavelength used or have a history of photosensitivity disorder
- Have tattoos in the treatment area
Additional Info
The purpose of this study is to determine whether the laser and RF study treatment combined with EMS together will reduce fat tissue and also tone muscle in the abdomen area. Also, the study will investigate whether the effects of the study treatments are maintained at 4 weeks and at 12 weeks.Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org